Latest News by Industry
CAMBRIDGE, Mass. (AP) _ Infinity Pharmaceuticals Inc. (INFI) on Monday reported a loss of $10.7 million in its third quarter.
On a per-share basis, the Cambridge, Massachusetts-based company said it had a loss of 12 cents.
The results did not meet Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 5 cents per share.
The drugmaker posted revenue of $712,000 in the period, also falling short of Street forecasts. Three analysts surveyed by Zacks expected $8.1 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a INFI">Zacks stock report on INFI at https://www.zacks.com/ap/INFI